SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies
2011 · Leukemia · 195 citations
https://doi.org/10.1038/leu.2011.148
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
422
Citations
3
h-index
3
i10-index
K C Goh is an academic researcher. The author has contributed to research in topics: Myeloproliferative Neoplasms: Diagnosis and Treatment & Acute Myeloid Leukemia Research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 3, co-authored 3 publications.
Click to start Chat